Therapeutic and Clinical Outcomes of Robot-assisted Partial Nephrectomy Versus Cryoablation for T1 Renal Cell Carcinoma
Toshihiro Uemura,Taigo Kato,Akira Nagahara,Atsunari Kawashima,Koji Hatano,Takeshi Ujike,Yusuke Ono,Hiroki Higashihara,Kazutoshi Fujita,Shinichiro Fukuhara,Hiroshi Kiuchi,Ryoichi Imamura,Noriyuki Tomiyama,Norio Nonomura,Motohide Uemura,TOSHIHIRO UEMURA,TAIGO KATO,AKIRA NAGAHARA,ATSUNARI KAWASHIMA,KOJI HATANO,TAKESHI UJIKE,YUSUKE ONO,HIROKI HIGASHIHARA,KAZUTOSHI FUJITA,SHINICHIRO FUKUHARA,HIROSHI KIUCHI,RYOICHI IMAMURA,NORIYUKI TOMIYAMA,NORIO NONOMURA,MOTOHIDE UEMURA
DOI: https://doi.org/10.21873/invivo.12413
2021-01-01
In Vivo
Abstract:BACKGROUND: In cT1 renal cell carcinoma (RCC), very few studies have compared oncological outcomes and renal function preservation rates in nephron-sparing robot-assisted partial nephrectomy (RAPN) and percutaneous cryoablation (PCA).PATIENTS AND METHODS: We retrospectively analysed 126 patients with cT1 RCC treated with RAPN (n=78) and computed tomography-guided PCA (n=48) between March 2016 and November 2019. Clinical data and outcomes were compared for the two groups.RESULTS: There were no significant differences in the 3-year overall survival and relapse-free survival rates in the two groups (p=0.17 and p=0.093, respectively). The median percentage of estimated glomerular filtration rate preservation at 6 months after surgery was 91.8% and 91.4% in the RAPN and PCA groups, respectively (p=0.9).CONCLUSION: In patients with cT1a RCC, oncological outcomes and renal function appear similar following RAPN and PCA.
medicine, research & experimental